Loganin alleviates macrophage infiltration and activation by inhibiting the MCP-1/CCR2 axis in diabetic nephropathy

Alantolactone mitigates renal injury induced by diabetes via inhibition of high glucose-mediated inflammatory response and macrophage infiltration

(2020) Yu Zhu et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Mesenchymal stem cells elicit macrophages into M2 phenotype via improving transcription factor EB-mediated autophagy to alleviate diabetic nephropathy

(2020) Yujia Yuan et al.   STEM CELLS

Eriodictyol inhibits high glucose‐induced extracellular matrix accumulation, oxidative stress, and inflammation in human glomerular mesangial cells

(2019) Jin Bai et al.   PHYTOTHERAPY RESEARCH

Luteolin Regulates Macrophage Polarization via the PI3K/Akt Pathway to Inhibit the Apoptosis Stimulated by Angiotensin Ⅱ

(2018) Qiao Jiang et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Role of TGF-β activated kinase-1 inhibitor on the interaction between macrophages and mesangial cells on the condition of high glucose

(2018) Zhe Fan et al.   IMMUNOLOGICAL INVESTIGATIONS

miR-374a Regulates Inflammatory Response in Diabetic Nephropathy by Targeting MCP-1 Expression

(2018) Zijun Yang et al.   Frontiers in Pharmacology

Regulation of RAW264.7 macrophage polarization on smooth and rough surface topographies by galectin-3

(2017) F. Kianoush et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN)

(2017) Yang Yuan et al.   Lipids in Health and Disease

The RhoA/ROCK Pathway Ameliorates Adhesion and Inflammatory Infiltration Induced by AGEs in Glomerular Endothelial Cells

(2017) Jialing Rao et al.   Scientific Reports

Loganin inhibits the inflammatory response in mouse 3T3L1 adipocytes and mouse model

(2016) Yang Li et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Loganin attenuates diabetic nephropathy in C57BL/6J mice with diabetes induced by streptozotocin and fed with diets containing high level of advanced glycation end products

(2015) Kai Liu et al.   LIFE SCIENCES

UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry

(2014) Ying-Yong Zhao et al.   CLINICAL BIOCHEMISTRY

Bioactive compounds from Cornus officinalis fruits and their effects on diabetic nephropathy

(2014) Wei Ma et al.   JOURNAL OF ETHNOPHARMACOLOGY

CCL2 Shapes Macrophage Polarization by GM-CSF and M-CSF: Identification of CCL2/CCR2-Dependent Gene Expression Profile

(2014) E. Sierra-Filardi et al.   JOURNAL OF IMMUNOLOGY

Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance

(2014) Nan Wang et al.   Frontiers in Immunology

Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice

(2012) Y. Nio et al.   DIABETOLOGIA

Macrophage plasticity and polarization: in vivo veritas

(2012) Antonio Sica et al.   JOURNAL OF CLINICAL INVESTIGATION

A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy

(2011) Yashpal S. Kanwar et al.   Annual Review of Pathology-Mechanisms of Disease

Calycosin protects HUVECs from advanced glycation end products-induced macrophage infiltration

(2011) Youhua Xu et al.   JOURNAL OF ETHNOPHARMACOLOGY

Distinct Macrophage Phenotypes Contribute to Kidney Injury and Repair

(2011) S. Lee et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Effect of loganin on experimental diabetic nephropathy

(2011) Wang-Lin Jiang et al.   PHYTOMEDICINE

Targeting the MCP-1/CCR2 System in Diabetic Kidney Disease

(2010) Sara Giunti et al.   Current Vascular Pharmacology

Macrophages and Diabetic Nephropathy

(2010) Greg H. Tesch   SEMINARS IN NEPHROLOGY

Global estimates of the prevalence of diabetes for 2010 and 2030

(2009) J.E. Shaw et al.   DIABETES RESEARCH AND CLINICAL PRACTICE